calpeptin has been researched along with Parkinsonian Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banik, NL; Cox, AA; Haque, A; Knaryan, VH; Samantaray, S; Shields, DC | 1 |
| Banik, NL; Butler, JT; Ray, SK; Samantaray, S | 1 |
| Ali, SF; Banik, NL; Ray, SK; Samantaray, S | 1 |
3 other study(ies) available for calpeptin and Parkinsonian Disorders
| Article | Year |
|---|---|
Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice.
Topics: Animals; Astrocytes; Calpain; Dipeptides; Dopaminergic Neurons; Gait Disorders, Neurologic; Inflammation; Lymphocyte Subsets; Macrophages; Male; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Nerve Tissue Proteins; Parkinsonian Disorders; Spinal Cord; Substantia Nigra | 2015 |
Extranigral neurodegeneration in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Calpain; Cell Line; Dipeptides; Humans; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Parkinsonian Disorders; Rotenone; Spinal Cord; Substantia Nigra; Uncoupling Agents | 2008 |
Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonism.
Topics: Animals; Apoptosis; Calpain; Cell Culture Techniques; Dipeptides; Disease Models, Animal; DNA Fragmentation; Humans; In Situ Nick-End Labeling; Motor Neurons; Parkinsonian Disorders; Rats | 2006 |